Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment-Reference-Cited by-同舟云学术

Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment

Published:2020-03-12 Issue:9 Volume:7 Page:1902971
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Delgado‐Martín Belén¹,Medina Miguel Ángel¹²³^ORCID

Affiliation:

1. Department of Molecular Biology and BiochemistryFaculty of SciencesCampus de Teatinos s/nUniversity of Málaga Málaga E‐29071 Spain

2. IBIMA (Biomedical Research Institute of Málaga) Málaga E‐29071 Spain

3. CIBER de Enfermedades Raras (CIBERER) Málaga E‐29071 Spain

Funder

Ministerio de Ciencia, Innovación y Universidades

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201902971

Reference161 articles.

1. The epidemiology of glioma in adults: a "state of the science" review

2. Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas

3. The Definition of Primary and Secondary Glioblastoma

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy;Biomaterials;2024-12

2. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations;International Journal of Biological Macromolecules;2024-10

3. Research progress on the mechanisms, assessment methods, and intervention strategies for glioma-related cognitive impairment;Asia-Pacific Journal of Oncology;2024-09-12

4. SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4;Journal of Experimental & Clinical Cancer Research;2024-08-19

5. Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling;Chemical Biology & Drug Design;2024-08